Elevated expression of Cripto-1 correlates with poor prognosis in non-small cell lung cancer

The IASLC Lung Cancer Staging Project: Validation of the Proposals for Revision of the T, N, and M Descriptors and Consequent Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours

Patti A. Groome, Vanessa Bolejack, John J. Crowley et al. · Journal of Thoracic Oncology · 2007 · 617 citations · Full text

Cancer Detection, Medicine, Malignant Tumours +8

Pentraxin-3 Is a Novel Biomarker of Lung Carcinoma

Eleftherios P. Diamandis, Lee Goodglick, Chris Planque et al. · Clinical Cancer Research · 2011 · 118 citations · Full text

Reactivation of embryonic nodal signaling is associated with tumor progression and promotes the growth of prostate cancer cells

Mitchell G. Lawrence, Naira V. Margaryan, Daniela Loessner et al. · The Prostate · 2011 · 103 citations

Identification of Cripto-1 as a Novel Serologic Marker for Breast and Colon Cancer

Caterina Bianco, Luigi Strizzi, Mario Mancino et al. · Clinical Cancer Research · 2006 · 82 citations

Positive association of up‐regulated Cripto‐1 and down‐regulated E‐cadherin with tumour progression and poor prognosis in gastric cancer

X‐Y Zhong, L.-H. Zhang, S‐Q Jia et al. · Histopathology · 2008 · 78 citations